Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent?

Completed · Phase 4

Conditions studied: Cardioprotective Levels

In brief

To demonstrate that RBC saturation of the Omega-3 fatty acids reaching cardioprotective levels as proven with the HS-Omega-3 Index test will be achieved most efficiently depending on a specific product utilized within this study.

Key facts

Study ID

NCT01091714

Run by

Bucci Laser Vision Institute

People needed

60

Starts

2010-10-01

Expected to finish

2011-07-01

Last updated by the study team

2011-10-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Willing and able to give written informed consent.
• Subject motivation and willingness to cooperate with the investigator by following the required medication regimen.
• Subject willingness and ability to return for all visits during the study.
• Must be willing to discontinue all use of Omega-3 supplementation 2 weeks prior to study participation.

You may not qualify if…

• Concurrent involvement in any other clinical trial involving an investigational drug or device.
• Compromised cognitive ability which may be expected to interfere with study compliance.
• Uncontrolled or poorly controlled systemic disease ot the presence of any significant illness that could, in the judgment of the investigator, jeopardize subject safety or interfere with the interpretation of the results of the study.
• Subjects must not eat more that 1 non-fried fish meal per week.
• Subjects must not have undergone any bariatric surgery or have a malabsorption disorder.

Where it is running

• Bucci Laser Vision Institute — Wilkes-Barre, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.